Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome

Abstract Background Hand-foot syndrome (HFS) is a common adverse event of capecitabine causing treatment modifications. Topical urea cream can reduce sorafenib-induced hand-foot skin reaction. However, its benefit in preventing capecitabine-associated HFS was not seen early in the course and had bee...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Concord Wongkraisri, Kriengkrai Chusuwanrak, Apirom Laocharoenkeat, Leena Chularojanamontri, Akarin Nimmannit, Suthinee Ithimakin
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-02-01
Sarja:	BMC Cancer
Aiheet:	Hand-foot syndrome Capecitabine Urea cream Prophylaxis
Linkit:	https://doi.org/10.1186/s12885-025-13684-1
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!